Melanoma News and Research

Latest Melanoma News and Research

People with diabetes mellitus have three to four times the risk of developing liver cancer

People with diabetes mellitus have three to four times the risk of developing liver cancer, and more than twice the risk of developing pancreatic cancer than non-diabetic individuals, according to research presented at the Third Annual Frontiers in Cancer Prevention Research Meeting in Seattle.

18 Oct 2004

Researchers discover mechanism that may help to explain how angiogenesis inhibitors work on normal, blood vessel-forming endothelial cells

Northwestern University researchers have discovered a mechanism that may help to explain how angiogenesis inhibitors work on normal, blood vessel-forming endothelial cells, but not on insidious, aggressive melanoma cells that masquerade as endothelial-like cells by forming their own vascular networks, called "vasculogenic mimicry."

8 Oct 2004

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Unlike traditional vaccines, cancer vaccines are not meant to be given to healthy people to prevent cancer. Rather, they are meant to be used in sick patients to strengthen their immune system to better fight the cancer.

4 Oct 2004

Skin cancer rates concern Australian health experts

Victorian Premier Steve Bracks joined The Cancer Council Victoria today to launch the 2004 SunSmart season. Releasing the latest skin cancer rates for Victoria, Professor David Hill, Director of the Cancer Council warned of the human and economic costs to all Victorians if skin cancer rates continue to increase.

30 Sep 2004

Cancer vaccine based on listeria bacteria shows promise

An experimental cancer vaccine using defanged listeria bacteria is showing great promise in animal studies, successfully treating new cancers that have spread into the lungs of mice.

29 Sep 2004

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Gene therapy that causes the bladder to act like a “bioreactor” to produce and secrete the anti-cancer agent interferon-alpha has shown dramatic benefits in preclinical tests, say researchers at The University of Texas M. D. Anderson Cancer Center.

8 Sep 2004

Researchers discover that DNA fragments destroy melanoma cells

Researchers at Boston University School of Medicine have discovered that small DNA fragments or oligonucleotides that resemble the telomere (chromosome end), also called T-oligos, can cause human melanoma cells to undergo extensive apoptosis (cell death), while surviving melanoma cells become more differentiated and therefore less aggressive.

1 Sep 2004

New treatment strategy for brain cancer

Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.

9 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.

5 Aug 2004

Successfully cloning mice from an advanced melanoma cell

Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.

3 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

An international team of scientists has identified an important molecular link involved in the spread – or metastasis – of melanoma to other organs such as the lungs.

15 Jul 2004

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Important milestone for any cancer therapy that will be useful for treating patients

Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs - and often cures - malignant melanoma, one of the most lethal forms of skin cancer and the most common cancer of young adults.

15 Jul 2004

British people should get out in the sun and not cover up for health reasons

British health is being put at risk by government policy that discourages sunbathing and promotes use of sunblock products. The cost of disease caused by insufficient exposure to sunlight and consequent deficiency of vitamin D is estimated to be billions of pounds per year in Britain.

5 Jul 2004

Melanoma News and Research

Latest Melanoma News and Research

People with diabetes mellitus have three to four times the risk of developing liver cancer

Researchers discover mechanism that may help to explain how angiogenesis inhibitors work on normal, blood vessel-forming endothelial cells

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Skin cancer rates concern Australian health experts

Cancer vaccine based on listeria bacteria shows promise

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Researchers discover that DNA fragments destroy melanoma cells

New treatment strategy for brain cancer

Australian university signs multi-million dollar anti-cancer research deal

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

Successfully cloning mice from an advanced melanoma cell

New approach to cancer vaccines may eradicate skin cancer tumors

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

New cream treatment for common form of skin cancer

A new vaccine that may delay cancer recurrence

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Important milestone for any cancer therapy that will be useful for treating patients

British people should get out in the sun and not cover up for health reasons

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in